My latest TCS column addresses the SEC's woefully inadequate action on controlling Sarbanes- Oxley compliance costs:
Unlike the recommendations made by its own Advisory Committee, which would have provided significant and comprehensive regulatory relief for smaller public corporations, the SEC has taken a narrow and trivial approach to the problem. It's like using a band-aid to fix a gaping puncture wound.
